Observational study / 2019
Elevated plasma vitamin B12 levels were linked to an increased 1-year risk of incident cancer in UK primary care patients.
Researchers analyzed 757,185 individuals without low B12, prior cancer, or B12 treatment from the UK Health Improvement Network primary care database to evaluate incident cancer risk across plasma B12 categories. Over 2,874,059 years of follow-up, 33,367 incident cancers were identified. Individuals with B12 levels >1,000 pmol/L had an adjusted 1-year cancer incidence rate ratio of 4.72 (95% CI: 3.99-5.58) compared to those with normal levels (150-600 pmol/L), showing a nonlinear dose-response pattern. Risks were particularly elevated for liver cancer, pancreas cancer, and myeloid malignancies.
Shows an association, not proof of cause and effect.
- Study type
- Cohort study
- Who was studied
- 757,185 persons with plasma vitamin B12 measurements from UK primary care
- What was measured
- Incident cancer risk
THE PAPER
Elevated Vitamin B12 Levels and Cancer Risk in UK Primary Care: A THIN Database Cohort Study.
Arendt JFH, Sørensen HT, Horsfall LJ, Petersen I. Cancer Epidemiol Biomarkers Prev, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.